| Next 10 |
Ad
BLCO News and Press Bausch + Lomb Corporation
News | Bausch + Lomb Corporation (NYSE:BLCO)
-
2024-12-02 16:12:22 ET More on Bausch + Lomb, Embecta, etc. Tandem Diabetes: Recurring Value Erosion, Not Right Point In Cycle To Own Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript Embecta Corp. 2024 Q4 - Results - Earnings Call Presentation Embecta ra...
-
2024-12-02 08:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-21 17:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 94,119,275 units*, or 569,743 pounds,...
-
2024-10-30 15:12:11 ET Bausch + Lomb Corporation (BLCO) Q3 2024 Results Conference Call October 30, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations and Business Insights Brenton Saunders - CEO & Chairman Osama Elde...
-
2024-10-30 07:32:44 ET More on Bausch + Lomb Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely With Buyout Interest, Bausch + Lomb May Still Be Worth Interest At Current Levels Bausch rejects latest bondholder debt proposals - WS...
-
American Superconductor Corporation (AMSC) is expected to report $0 for Q2 2025 Accel Entertainment Inc. (ACEL) is expected to report $0.16 for Q3 2024 C.H. Robinson Worldwide Inc. (CHRW) is expected to report $1.12 for Q3 2024 The Vita Coco Company Inc. (COCO) is expected to report $...
-
Revenue of $1.196 Billion GAAP Net Income Attributable to Bausch + Lomb Corporation of $4 Million Adjusted EBITDA (non-GAAP) 1 of $212 Million; Adjusted EBITDA excluding Acquired IPR&D (non-GAAP) 1 of $227 Million Revenue Grew 19% as Reported and 19% on...
-
2024-10-17 17:17:04 ET More on Bausch Health, Bausch + Lomb Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely With Buyout Interest, Bausch + Lomb May Still Be Worth Interest At Current Levels Bausch Health Companies (BHC) Q2 2024...
-
2024-10-15 15:27:06 ET More on Bausch + Lomb Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely With Buyout Interest, Bausch + Lomb May Still Be Worth Interest At Current Levels Bausch + Lomb Corporation 2024 Q2 - Results - Earnin...
Stock Information
Get BLCO Alerts
News, Short Squeeze, Breakout and More Instantly...
Bausch + Lomb Corporation Company Name:
BLCO Stock Symbol:
NYSE Market:
Bausch + Lomb Corporation Website:
Ad
-
2024-12-02 08:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-21 17:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 94,119,275 units*, or 569,743 pounds,...